SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-068770
Filing Date
2024-06-04
Accepted
2024-06-04 16:45:03
Documents
2
Period of Report
2024-05-31

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7664
2 EX-24.1 aktx-ex24_1.htm EX-24.1 15238
  Complete submission text file 0000950170-24-068770.txt   24577
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Issuer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 71 SHEPHERDS HILL LONDON X0 N6 5RE
Business Address
Prudo-Chlebosz Raymond (Reporting) CIK: 0001653262 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36288 | Film No.: 241018913